| Literature DB >> 32138165 |
Kaijie Yang1, Jue Wang1, Kejun Wang1,2, Yabiao Luo1, Qiguo Tang1, Ximing Liu1, Meiying Fang1.
Abstract
Embryo loss is a major factor affecting profitability in the pig industry. Embryonic mortality occurs during peri-implantation and mid-late gestation in pigs. Previous investigations have shown that the embryo loss rate in Meishan pigs is significantly lower than in commercial breeds. Most studies have focused on embryonic mortality during early gestation, but little is known about losses during mid-late gestation. In this study, we performed a transcriptome analysis of endometrial tissue in mid-late gestation sows (gestation days 49 and 72) sampled from two breeds (Meishan (MS) and Duroc (DU)) that have different embryo loss rates. We identified 411, 1113, 697, and 327 differentially expressed genes, and 14, 36, 57, and 43 differentially expressed miRNAs in four comparisons (DU49 vs. DU72, DU49 vs. MS49, DU72 vs. MS72, and MS49 vs. MS72), respectively. Subsequently; seven differentially expressed mRNAs and miRNAs were validated using qPCR. Functional analysis suggested the differentially expressed genes and miRNAs target genes mainly involved in regulation of hormone levels, blood vessel development, developmental process involved in reproduction, embryonic placenta development, and the immune system. A network analysis of potential miRNA-gene interactions revealed that differentially expressed miRNAs in Meishan pigs are involved in the response to estradiol and oxygen levels, and affect angiogenesis and blood vessel development. The binding site on ssc-miR-503 for epidermal growth factor (EGF) and the binding site on ssc-miR-671-5p for estrogen receptor α (ESR1) were identified using a dual luciferase assay. The results of this study will enable further exploration of miRNA-mRNA interactions important in pig pregnancy and will help to uncover molecular mechanisms affecting embryonic mortality in pigs during mid-late gestation.Entities:
Keywords: Meishan and Duroc sows; RNA-seq; endometrium; miRNA-mRNA interaction
Year: 2020 PMID: 32138165 PMCID: PMC7143271 DOI: 10.3390/ani10030420
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 2.752
Number of differentially expressed mRNAs and miRNAs.
| Comparison | DE mRNAs | DE miRNAs | ||||
|---|---|---|---|---|---|---|
| Total | Up | Down | Total | Up | Down | |
| DU49 vs. DU72 | 411 | 273 | 138 | 14 | 10 | 4 |
| DU49 vs. MS49 | 1113 | 678 | 435 | 36 | 24 | 8 |
| DU72 vs. MS72 | 697 | 397 | 300 | 57 | 26 | 31 |
| MS49 vs. MS72 | 327 | 185 | 142 | 43 | 21 | 22 |
Differentially expressed genes associated with fetal loss or litter size based on previous studies.
| Comparison Group | Ensembl ID | Gene Name | Log2 Fold Change | Adjusted |
|---|---|---|---|---|
| DU49 vs. DU72 | ENSSSCG00000030484 | −0.62 | 0.0247 | |
| ENSSSCG00000004283 | 4.68 | 0.0098 | ||
| ENSSSCG00000010698 | 0.96 | 0.0446 | ||
| ENSSSCG00000012229 | −0.74 | 0.0467 | ||
| ENSSSCG00000015579 | 1.85 | 0.0031 | ||
| ENSSSCG00000037754 | 1.08 | 0.0235 | ||
| DU49 vs. MS49 | ENSSSCG00000013303 | −0.98 | 0.0497 | |
| ENSSSCG00000017101 | −1.35 | 0.0137 | ||
| ENSSSCG00000011437 | 1.33 | 0.0283 | ||
| ENSSSCG00000025578 | −1.24 | 0.0422 | ||
| ENSSSCG00000004283 |
| 3.85 | 3.66 × 10−6 | |
| ENSSSCG00000012229 |
| −1.05 | 0.0174 | |
| ENSSSCG00000016204 | −1.50 | 0.0049 | ||
| ENSSSCG00000040575 | −1.23 | 0.0171 | ||
| ENSSSCG00000015579 |
| 1.87 | 0.0419 | |
| ENSSSCG00000007836 | 1.44 | 0.0412 | ||
| DU72 vs. MS72 | ENSSSCG00000009134 | −1.57 | 0.0012 | |
| ENSSSCG00000014336 | −1.44 | 3.75 × 10−6 | ||
| ENSSSCG00000002383 | −0.79 | 0.0040 | ||
| ENSSSCG00000010639 | 2.48 | 0.0248 | ||
| ENSSSCG00000016204 |
| 2.20 | 5.36 × 10−8 | |
| ENSSSCG00000040575 |
| −1.01 | 0.0059 | |
| ENSSSCG00000000455 | 2.14 | 1.37 × 10−10 | ||
| MS49 vs. MS72 | ENSSSCG00000014336 |
| −1.59 | 0.0002 |
| ENSSSCG00000025777 | 0.85 | 0.0036 | ||
| ENSSSCG00000002383 |
| −1.34 | 9.03 × 10−8 | |
| ENSSSCG00000015144 | −1.39 | 0.0294 | ||
| ENSSSCG00000016204 |
| 4.13 | 6.46 × 10−19 |
Figure 1Venn diagram displaying the overlap among different groups of differentially expressed genes (DEGs) (A), differentially expressed (DE) miRNAs (B).
Figure 2Pathways clustered from DEGs detected between GD49 and GD72. Top 20 non-redundant enriched gene ontology (GO) terms (A,B) and top 20 enriched KEGG pathways (C,D).
Figure 3Pathways clustered from DEGs detected between Duroc and Meishan sows. Top 20 non-redundant enriched GO terms (A,B) and top 20 KEGG pathways (C,D).
Figure 4miRNA-gene interaction network (DU49 vs. DU72). Large and small circles represent miRNAs and genes, respectively. Red indicates that the RNA is relatively more abundant, and green indicates that the RNA is relatively less abundant in DU49 than in DU72.
Figure 5miRNA-gene interaction network (DU49 vs. MS49). Large and small circles represent miRNAs and genes, respectively. Red indicates that the RNA is relatively more abundant, and green indicates that the RNA is relatively less abundant in DU49 than in MS49.
Figure 6miRNA-gene interaction network (DU72 vs. MS72). Large and small circles represent miRNAs and genes, respectively. Red indicates that the RNA is relatively more abundant, and green indicates that the RNA is relatively less abundant in DU72 than in MS72.
Figure 7miRNA-gene interaction network (MS49 vs. MS72). Large and small circles represent miRNAs and genes, respectively. Red indicates that the RNA is relatively more abundant, and green indicates that the RNA is relatively less abundant in MS49 than in MS72.
Significantly enriched GO terms and associated KEGG pathways shared between DU72 vs. MS72 and MS49 vs. MS72 in miRNA-mRNA interaction networks.
| Comparison Group | Terms | DEGs No. | Genes | |
|---|---|---|---|---|
| DU72 vs. MS72 | GO:0032355 ~ Response to estradiol | 7 | 0.00025 |
|
| GO:0070482 ~ Response to oxygen levels | 10 | 0.00379 |
| |
| GO:0001525 ~ Angiogenesis | 13 | 0.00337 |
| |
| GO:0001568 ~ Blood vessel development | 15 | 0.00497 |
| |
| ssc04015 ~ Rap1 signaling pathway | 4 | 3.52 × 10−5 |
| |
| ssc04014 ~ Ras signaling pathway | 4 | 5.41 × 10−5 |
| |
| ssc04151 ~ PI3K-Akt signaling pathway | 3 | 0.00019 |
| |
| ssc04068 ~ FoxO signaling pathway | 4 | 0.00031 |
| |
| MS49 vs. MS72 | GO:0032355 ~ Response to estradiol | 5 | 0.00037 |
|
| GO:0070482 ~ Response to oxygen levels | 8 | 0.00045 |
| |
| GO:0001525 ~ Angiogenesis | 8 | 0.00550 |
| |
| GO:0001568 ~ Blood vessel development | 9 | 0.00809 |
| |
| ssc04015 ~ Rap1 signaling pathway | 2 | 0.00580 |
| |
| ssc04014 ~ Ras signaling pathway | 3 | 0.00026 |
| |
| ssc04151 ~ PI3K-Akt signaling pathway | 4 | 2.26 × 10−5 |
| |
| ssc04068 ~ FoxO signaling pathway | 2 | 0.00291 |
|
Figure 8Quantitative PCR validation. The x-axis represents the different stages and breeds and the y-axis shows the fold changes in expression (* p < 0.05, ** p < 0.01). (A) APLN; (B) CDHR2; (C) EGF; (D) EGR1; (E) ESR1; (F) IHH; (G) NPTX1; (H) ssc-miR-19b; (I) ssc-miR-23a; (J) ssc-miR-30c-3p; (K) ssc-miR-452; (L) ssc-miR-503; (M) ssc-miR-671-5p; (N) ssc-miR-9-1. Relative expression values were normalized as descried in Materials and Methods.
Figure 9Validation of miRNA-gene interactions. (A) Validating EGF as a target of ssc-miR-503, (B) validating ESR1 as a target of ssc-miR-671-5p. (* p < 0.05, ** p < 0.01). WT, wild type; MT, mutant type.